Oportuzumab Monatox is an immunotoxin, binding specifically to the epithelial cell adhesion molecule (EpCAM), which is a transmembrane glycoprotein, frequently overexpressed in different cancers (193), inter alia malignancies of the colon, intestine, breast, lung, and prostate (194). The gene discussed is EPCAM; the disease is cancer.